GO:0004720 protein-lysine 6-oxidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004720 (protein-lysine 6-oxidase activity) catalyzes the oxidative deamination of lysine residues in proteins, producing reactive aldehydes that drive covalent crosslinking of extracellular matrix components.
• The reaction consumes oxygen and water and releases hydrogen peroxide and ammonium, and it requires copper and a quinone cofactor for catalysis.
• The LOX family (LOX, LOXL1, LOXL2, LOXL3, LOXL4) are the principal enzymes annotated with this activity and are central to collagen and elastin crosslinking.
• Dysregulated protein-lysine 6-oxidase activity contributes to fibrosis, cancer progression, cardiovascular calcification, and hypoxic-ischemic brain damage.
• Small-molecule LOX inhibitors and genetic models are actively used to dissect its roles in tumor microenvironment remodeling and chemoresistance.
• CRISPR knockout, point-mutation, knock-in, and overexpression cell models enable precise interrogation of LOX-family gene function in disease-relevant contexts.
Description
Protein-lysine 6-oxidase activity (GO:0004720) is a copper-dependent molecular function that oxidatively deaminates specific lysine residues within protein substrates, converting them to reactive aldehyde species. This activity is best known for its role in the extracellular matrix, where the resulting aldehydes spontaneously condense with neighboring lysine or hydroxylysine residues to form covalent crosslinks that stabilize collagen and elastin fibrils. The reaction is formally described as the conversion of an L-lysyl residue in a protein, in the presence of oxygen and water, to an (S)-2-amino-6-oxohexanoyl residue, with concomitant release of hydrogen peroxide and ammonium. The enzymes responsible for this activity belong to the lysyl oxidase (LOX) family, which includes LOX and the LOX-like proteins LOXL1-LOXL4. These enzymes are secreted and act in the extracellular space, where they shape the mechanical and biochemical properties of connective tissues. Beyond structural roles, protein-lysine 6-oxidase activity influences cell signaling, proliferation, and differentiation through remodeling of the extracellular matrix and generation of hydrogen peroxide as a signaling molecule. Because of its broad impact on tissue architecture and cell behavior, protein-lysine 6-oxidase activity is a focus of research in fibrosis, cancer, cardiovascular disease, and neurological injury. Understanding its catalytic mechanism, regulation, and downstream effects is essential for developing targeted therapies that modulate extracellular matrix crosslinking.
protein-lysine 6-oxidase activity At A Glance
| GO ID | GO:0004720 |
|---|---|
| GO term | protein-lysine 6-oxidase activity |
| Ontology | molecular_function |
| Synonym | lysyl oxidase activity; protein-L-lysine:oxygen 6-oxidoreductase (deaminating) |
| Major function | Oxidative deamination of lysine residues in proteins to form reactive aldehydes, enabling covalent crosslinking of extracellular matrix components. |
| Cofactors | Copper ion and a quinone cofactor (lysine tyrosylquinone) are required for catalysis. |
| Substrates | Lysine residues within collagen, elastin, and other extracellular matrix proteins. |
| Products | Aldehyde-modified protein, hydrogen peroxide, and ammonium. |
| Cellular location | Secreted; acts in the extracellular space. |
| Representative genes | LOX, LOXL1, LOXL2, LOXL3, LOXL4. |
What Is GO:0004720?
Protein-lysine 6-oxidase activity (GO:0004720) is defined as the catalysis of the reaction: L-lysyl-[protein] + O2 + H2O = (S)-2-amino-6-oxohexanoyl-[protein] + H2O2 + NH4+. In other words, it is the oxidative deamination of a lysine residue within a protein substrate, generating an aldehyde-bearing product, hydrogen peroxide, and ammonium. This activity is synonymous with lysyl oxidase activity and protein-L-lysine:oxygen 6-oxidoreductase (deaminating).
Why Is protein-lysine 6-oxidase activity Important in Cell Biology?
Protein-lysine 6-oxidase activity is essential for the structural integrity of connective tissues, as it initiates covalent crosslinking of collagen and elastin, which provides tensile strength and elasticity to skin, blood vessels, lungs, and other organs. Beyond its structural role, this activity generates hydrogen peroxide and modulates extracellular matrix stiffness, thereby influencing cell signaling pathways that control proliferation, migration, and differentiation. Dysregulation of protein-lysine 6-oxidase activity is implicated in a wide range of pathologies, including liver fibrosis, cancer progression and metastasis, cardiovascular calcification, and hypoxic-ischemic brain damage. Consequently, it is a promising therapeutic target, and small-molecule inhibitors are being developed to modulate its activity in disease settings.
• Drives collagen and elastin crosslinking, which is fundamental for extracellular matrix stability and tissue mechanics.
• Generates hydrogen peroxide, a signaling molecule that can influence cellular redox state and proliferation.
• Promotes fibrosis in liver and other organs by increasing matrix stiffness and crosslinking.
• Enhances tumor progression, epithelial-mesenchymal transition, and chemoresistance in multiple cancers.
• Contributes to cardiovascular calcification and aortic valve disease through matrix remodeling.
• Is involved in hypoxic-ischemic brain damage via mechanical stress and Piezo1 activation.
• Serves as a therapeutic target; LOX inhibitors are being explored to improve chemoresponse.
• Its copper-dependent catalysis links dietary copper status to connective tissue health.
• Modulates immune responses, including PD-L1 expression in gastric cancer.
• Provides a mechanistic link between extracellular matrix remodeling and stemness in cholangiocarcinoma.
Molecular Mechanism of protein-lysine 6-oxidase activity
Substrate recognition and lysine oxidation
In simple terms: The enzyme finds specific lysine residues in proteins like collagen and converts them into reactive aldehydes.
Protein-lysine 6-oxidase activity targets lysine residues within protein substrates, particularly in collagen and elastin. The enzyme binds the substrate and catalyzes the oxidative deamination of the epsilon-amino group of lysine, yielding an aldehyde-bearing residue known as allysine. This reaction is highly specific for lysine and requires molecular oxygen and water.
Catalytic cycle and cofactors
In simple terms: The enzyme uses copper and a special quinone cofactor to perform the oxidation.
The catalytic mechanism of protein-lysine 6-oxidase activity depends on a copper ion and a quinone cofactor, identified as lysine tyrosylquinone (LTQ) in the LOX family. The quinone cofactor participates in a redox cycle, accepting electrons from the lysine substrate and transferring them to oxygen, resulting in the formation of hydrogen peroxide and ammonium. Copper is essential for the biogenesis and activity of the enzyme, and copper deficiency impairs crosslinking.
Product formation and crosslinking
In simple terms: The aldehyde products spontaneously react with nearby lysines to form strong crosslinks between protein chains.
The aldehyde product of protein-lysine 6-oxidase activity, allysine, is highly reactive and can spontaneously condense with neighboring lysine or hydroxylysine residues, forming covalent crosslinks such as lysinonorleucine and pyridinoline. These crosslinks stabilize the extracellular matrix and are critical for the tensile strength of collagen fibrils and the elasticity of elastin. The hydrogen peroxide produced during the reaction can also influence cellular signaling and oxidative stress.
Regulation of enzyme activity
In simple terms: The amount and activity of the enzyme are controlled by gene expression, copper availability, and extracellular factors.
Protein-lysine 6-oxidase activity is regulated at multiple levels, including transcriptional control by hypoxia-inducible factors and growth factors such as TGF-beta. Copper availability is critical for the catalytic function, as the enzyme requires copper for its active site. Additionally, the activity can be modulated by extracellular matrix components and mechanical forces, which influence enzyme secretion and substrate accessibility. Small-molecule inhibitors have been developed to specifically block this activity in disease models.
Key Genes Involved in GO:0004720 protein-lysine 6-oxidase activity
The following genes encode proteins that exhibit protein-lysine 6-oxidase activity or are directly involved in its regulation and downstream effects.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LOX | Primary enzyme with protein-lysine 6-oxidase activity; crosslinks collagen and elastin. | Central to fibrosis, cancer, and cardiovascular research. |
| LOXL1 | Lysyl oxidase-like 1; contributes to elastin crosslinking. | Implicated in exfoliation syndrome and connective tissue disorders. |
| LOXL2 | Lysyl oxidase-like 2; involved in extracellular matrix remodeling and cancer progression. | Target in cholangiocarcinoma and other cancers. |
| LOXL3 | Lysyl oxidase-like 3; plays roles in development and tissue homeostasis. | Studied in developmental biology and cancer. |
| LOXL4 | Lysyl oxidase-like 4; involved in matrix crosslinking and tumor biology. | Potential biomarker in head and neck cancers. |
| COL1A1 | Major substrate of LOX; collagen type I alpha 1 chain. | Mutations cause osteogenesis imperfecta; model for crosslinking studies. |
| COL3A1 | Collagen type III alpha 1 chain; substrate for crosslinking. | Vascular Ehlers-Danlos syndrome research. |
| ELN | Elastin; substrate for LOX-mediated crosslinking. | Elastinopathies and cardiovascular research. |
| TGFB1 | Induces LOX expression and promotes fibrosis. | Therapeutic target in fibrosis and cancer. |
| HIF1A | Hypoxia-inducible factor 1 alpha; upregulates LOX under hypoxia. | Hypoxic-ischemic injury and tumor hypoxia studies. |
| PIEZO1 | Mechanosensitive ion channel activated by LOX-mediated matrix stress. | Neuronal injury and mechanotransduction research. |
| CD274 | PD-L1; expression regulated by LOX-driven histone lactylation. | Immuno-oncology and gastric cancer research. |
| SNAI1 | Snail family transcriptional repressor 1; induced by LOX via TGF-beta/IGF1 signaling. | EMT and metastasis studies. |
| SNAI2 | Snail family transcriptional repressor 2; involved in EMT downstream of LOX. | Cancer invasion research. |
| IGF1 | Insulin-like growth factor 1; mediates LOX effects on EMT. | Tumor microenvironment studies. |
| ATP7A | Copper transporter; supplies copper for LOX activity. | Copper metabolism and connective tissue research. |
| CCS | Copper chaperone for superoxide dismutase; may influence copper availability for LOX. | Copper homeostasis studies. |
| SLC31A1 | Copper transporter 1; involved in copper uptake for LOX. | Copper transport and LOX function research. |
How Is protein-lysine 6-oxidase activity Regulated?
Protein-lysine 6-oxidase activity is regulated at transcriptional, post-transcriptional, and post-translational levels. Hypoxia-inducible factor 1 alpha (HIF1A) upregulates LOX expression under hypoxic conditions, linking oxygen availability to matrix remodeling. Transforming growth factor beta (TGFB1) is a potent inducer of LOX family members, promoting fibrosis and cancer progression. Copper availability, mediated by transporters such as ATP7A and SLC31A1, is essential for the catalytic activity of the enzyme. Additionally, extracellular matrix mechanical stress can feed back to regulate LOX activity and downstream signaling through Piezo1. Small-molecule inhibitors and genetic tools are used to modulate this activity in experimental settings.
protein-lysine 6-oxidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LOX | Liver fibrosis; cancer progression | LOX knockout hepatic stellate cells; overexpression in cancer cell lines |
| LOXL2 | Cholangiocarcinoma stemness and oxidative phosphorylation | LOXL2 knockout cholangiocarcinoma cells; fibroblast co-culture |
| LOX | Gastric cancer EMT and PD-L1 regulation | LOX overexpression in gastric cancer cells; PD-L1 reporter assays |
| LOX | Cardiovascular calcification and aortic valve disease | LOX knockout vascular smooth muscle cells; calcification induction |
| LOX | Hypoxic-ischemic brain damage via Piezo1 | LOX inhibitor treatment in neuronal hypoxia models |
Liver fibrosis and fibrosis-related diseases
Protein-lysine 6-oxidase activity is a key driver of liver fibrosis, where excessive crosslinking of collagen increases matrix stiffness and promotes disease progression. LOX family members are upregulated in fibrotic liver and contribute to the accumulation of scar tissue. Targeting LOX activity with inhibitors or genetic knockdown reduces fibrosis in preclinical models, highlighting its therapeutic potential.
Cancer progression and metastasis
In multiple cancers, including cholangiocarcinoma, gastric cancer, and triple-negative breast cancer, LOX-mediated crosslinking remodels the tumor microenvironment, promoting invasion, metastasis, and chemoresistance. LOX secreted by cancer-associated fibroblasts increases oxidative phosphorylation and stemness in cholangiocarcinoma cells. In gastric cancer, LOX promotes PD-L1 expression via histone lactylation and regulates epithelial-mesenchymal transition through TGF-beta/IGF1 signaling. Inhibitors of LOX activity enhance chemoresponse in breast cancer models.
Cardiovascular calcification and aortic valve disease
Lysyl oxidase-dependent extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease. Dysregulated LOX activity alters matrix stiffness and promotes osteogenic differentiation of valve interstitial cells, contributing to calcific aortic valve disease. Modulating LOX activity may offer a strategy to prevent or slow cardiovascular calcification.
Hypoxic-ischemic brain damage
In hypoxic-ischemic brain damage, LOX-mediated extracellular matrix mechanical stress activates the mechanosensitive ion channel Piezo1, contributing to neuronal injury. Inhibition of LOX activity with novel inhibitors reduces Piezo1 activation and may protect against brain damage. This highlights a role for protein-lysine 6-oxidase activity beyond connective tissue, in acute neurological injury.
From protein-lysine 6-oxidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LOX reduce collagen crosslinking and fibrosis? | LOX knockout in hepatic stellate cells or mouse models |
| Does a specific point mutation in the LOX catalytic domain abolish enzymatic activity? | Point-mutation knock-in of LOX catalytic residues in cell lines |
| Does tagging LOX with a fluorescent protein affect its secretion and localization? | Knock-in of fluorescent tag at the LOX locus |
| Does overexpression of LOXL2 enhance cancer stemness? | LOXL2 overexpression in cholangiocarcinoma cells |
| Does LOX-mediated PD-L1 upregulation depend on histone lactylation? | LOX overexpression with lactylation inhibitors in gastric cancer cells |
| Can LOX inhibitors enhance chemosensitivity in breast cancer? | Triple-negative breast cancer cells treated with LOX inhibitors |
How to Study the protein-lysine 6-oxidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Amplex Red assay | Hydrogen peroxide production from LOX activity | Quantifying enzyme activity in cell lysates |
| Pyridinoline crosslink assay | Collagen crosslinking | Assessing matrix maturation in fibrosis models |
| Mass spectrometry | Allysine and crosslink sites in proteins | Mapping LOX substrate specificity |
| RNA-seq | Transcriptional changes upon LOX modulation | Identifying downstream pathways in cancer |
| Western blot | Protein expression and secretion of LOX family members | Validating knockout or overexpression |
| Immunofluorescence | Cellular localization of LOX and matrix proteins | Studying extracellular matrix remodeling |
| Mechanical testing | Tissue stiffness and elasticity | Evaluating functional impact of crosslinking |
| CRISPR screening | Genes affecting LOX activity or crosslinking | Identifying regulators of extracellular matrix |
Enzymatic activity assays
Protein-lysine 6-oxidase activity can be measured using fluorometric or colorimetric assays that detect hydrogen peroxide or aldehyde products generated during the reaction. These assays are typically performed with purified enzyme or cell lysates and specific substrates such as collagen or synthetic peptides. Amplex Red or similar probes are commonly used to quantify hydrogen peroxide production.
Extracellular matrix crosslinking analysis
Crosslinking of collagen and elastin can be assessed by biochemical methods that quantify pyridinoline or desmosine content, or by mechanical testing of tissue stiffness. Mass spectrometry-based proteomics can identify specific crosslinked sites and allysine modifications. These methods are essential for linking enzyme activity to functional matrix changes.
Gene expression and regulation studies
Quantitative RT-PCR, RNA-seq, and promoter reporter assays are used to study transcriptional regulation of LOX family genes under hypoxia, TGF-beta stimulation, or other conditions. Western blotting and immunofluorescence can detect protein levels and localization. CRISPR interference or activation can be used to modulate gene expression precisely.
In vivo and ex vivo models
Animal models of fibrosis, cancer, and cardiovascular disease are used to study the role of protein-lysine 6-oxidase activity in vivo. Ex vivo tissue explants and organoids can provide more controlled environments to test inhibitors or genetic manipulations. These models help translate findings from cell culture to whole-organism physiology.
How CRISPR Can Be Used to Study GO:0004720 protein-lysine 6-oxidase activity
Knockout
CRISPR knockout of LOX family genes in cell lines or primary cells abolishes protein-lysine 6-oxidase activity, allowing researchers to study loss-of-function phenotypes such as reduced collagen crosslinking, decreased matrix stiffness, and altered cell signaling. Knockout models are valuable for validating the role of specific LOX isoforms in fibrosis and cancer.
Point Mutation
Point mutations can be introduced into the catalytic domain of LOX to dissect the enzymatic mechanism, for example by mutating the copper-binding residues or the lysine tyrosylquinone precursor tyrosine. Such models help distinguish catalytic activity from non-enzymatic functions of LOX proteins.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous LOX locus enables real-time tracking of enzyme secretion, localization, and interaction with matrix substrates. Knock-in of disease-associated mutations can model human connective tissue disorders.
Overexpression
Overexpression of LOX or LOXL2 in cancer cell lines or fibroblasts increases protein-lysine 6-oxidase activity, promoting matrix crosslinking, EMT, and chemoresistance. Overexpression models are used to test LOX inhibitors and to identify downstream signaling pathways.
How EDITGENE Supports protein-lysine 6-oxidase activity Research
Researchers studying protein-lysine 6-oxidase activity-related genes often need to determine whether a candidate gene is causally involved in extracellular matrix remodeling, fibrosis, or cancer progression. Precise genetic models are essential to link enzyme activity to specific phenotypes and to validate therapeutic targets.
Contact EDITGENE today to design your custom CRISPR model for protein-lysine 6-oxidase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| LOX Knockout HEK293 Cell Line | EDJ-KQ3160 | Human | 4015 | Details Get a Quote |
| LOXL1 Knockout HEK293 Cell Line | EDJ-KQ5137 | Human | 4016 | Details Get a Quote |
| LOXL4 Knockout HEK293 Cell Line | EDJ-KQ10000 | Human | 84171 | Details Get a Quote |
| LOXL3 Knockout HEK293 Cell Line | EDJ-KQ10168 | Human | 84695 | Details Get a Quote |
| LOXL2 Knockout HEK293 Cell Line | EDJ-KQ17787 | Human | 4017 | Details Get a Quote |
| LOXL1 Knockout HCT 116 Cell Line | EDJ-KQ28100 | Human | 4016 | Details Get a Quote |
| LOXL1 Knockout HeLa Cell Line | EDJ-KQ28101 | Human | 4016 | Details Get a Quote |
| LOXL4 Knockout A-549 Cell Line | EDJ-KQ36964 | Human | 84171 | Details Get a Quote |
| LOXL4 Knockout HCT 116 Cell Line | EDJ-KQ36965 | Human | 84171 | Details Get a Quote |
| LOXL4 Knockout HeLa Cell Line | EDJ-KQ36966 | Human | 84171 | Details Get a Quote |
| LOXL2 Knockout HCT 116 Cell Line | EDJ-KQ18544 | Human | 4017 | Details Get a Quote |
| LOXL2 Knockout A-549 Cell Line | EDJ-KQ19870 | Human | 4017 | Details Get a Quote |
| LOXL2 Knockout HeLa Cell Line | EDJ-KQ19871 | Human | 4017 | Details Get a Quote |
| LOX Knockout HCT 116 Cell Line | EDJ-KQ24568 | Human | 4015 | Details Get a Quote |
| LOX Knockout HeLa Cell Line | EDJ-KQ24569 | Human | 4015 | Details Get a Quote |
Frequently Asked Questions About protein-lysine 6-oxidase activity
What is protein-lysine 6-oxidase activity?
Protein-lysine 6-oxidase activity (GO:0004720) is the catalytic oxidative deamination of lysine residues in proteins, producing reactive aldehydes, hydrogen peroxide, and ammonium, which drives extracellular matrix crosslinking.
What genes are involved in protein-lysine 6-oxidase activity?
The main genes are LOX, LOXL1, LOXL2, LOXL3, and LOXL4, which encode lysyl oxidase family enzymes.
What is the reaction catalyzed by protein-lysine 6-oxidase?
It catalyzes L-lysyl-[protein] + O2 + H2O = (S)-2-amino-6-oxohexanoyl-[protein] + H2O2 + NH4+.
What cofactors are required for protein-lysine 6-oxidase activity?
The enzyme requires copper and a quinone cofactor, lysine tyrosylquinone, for catalysis.
How is protein-lysine 6-oxidase activity regulated?
It is regulated by hypoxia-inducible factors, TGF-beta signaling, copper availability, and extracellular matrix mechanical cues.
What diseases are associated with protein-lysine 6-oxidase activity?
It is implicated in liver fibrosis, cancer progression, cardiovascular calcification, and hypoxic-ischemic brain damage.
How can I measure protein-lysine 6-oxidase activity in the lab?
Common methods include Amplex Red assays for hydrogen peroxide, crosslink quantification, and mass spectrometry for allysine detection.
What CRISPR models are available for studying LOX genes?
Knockout, point mutation, knock-in, and overexpression models can be generated in relevant cell types to study LOX function.
Why is protein-lysine 6-oxidase activity important in cancer?
It remodels the tumor microenvironment, promotes EMT, stemness, and chemoresistance, and regulates immune checkpoint expression.
Can protein-lysine 6-oxidase activity be inhibited therapeutically?
Yes, small-molecule inhibitors of LOX have shown efficacy in preclinical models of fibrosis and cancer.
Conclusion
Protein-lysine 6-oxidase activity (GO:0004720) is a fundamental enzymatic function that drives extracellular matrix crosslinking and influences diverse biological processes, from tissue integrity to cancer progression. Its copper-dependent catalytic mechanism and regulation by hypoxia and growth factors make it a critical node in fibrosis, cardiovascular disease, and neurological injury. Continued research using precise CRISPR models and biochemical assays will further elucidate its roles and facilitate the development of targeted therapies.
References
- 1. Chen W et al.. 2020. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis.. Hepatology 72(2):729-741 PMID: 32176358
- 2. Jiang D et al.. 2024. LOX-mediated ECM mechanical stress induces Piezo1 activation in hypoxic-ischemic brain damage and identification of novel inhibitor of LOX.. Redox Biol 76:103346 PMID: 39260063
- 3. Anthony C. 1996. Quinoprotein-catalysed reactions.. Biochem J 320 ( Pt 3)(Pt 3):697-711 PMID: 9003352
- 4. Lewinska M et al.. 2024. Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma.. Gastroenterology 166(5):886-901.e7 PMID: 38096955
- 5. Li Z et al.. 2024. CAF-secreted LOX promotes PD-L1 expression via histone Lactylation and regulates tumor EMT through TGFβ/IGF1 signaling in gastric Cancer.. Cell Signal 124:111462 PMID: 39395525
- 6. Cetin M et al.. 2024. A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer.. Cell Chem Biol 31(11):1926-1941.e11 PMID: 39043186
- 7. Ballester-Servera C et al.. 2023. Lysyl oxidase-dependent extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease.. Biomed Pharmacother 167:115469 PMID: 37729730
- 8. Rucker RB et al.. 1998. Copper, lysyl oxidase, and extracellular matrix protein cross-linking.. Am J Clin Nutr 67(5 Suppl):996S-1002S PMID: 9587142
